piracetam has been researched along with Panic Disorder in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open-label, fixed-flexible dose study, 18 patients with panic disorder with or without agoraphobia (DSM-IV diagnostic criteria) were treated with levetiracetam for 12 weeks." | 9.12 | Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. ( Papp, LA, 2006) |
| "In an open-label, fixed-flexible dose study, 18 patients with panic disorder with or without agoraphobia (DSM-IV diagnostic criteria) were treated with levetiracetam for 12 weeks." | 5.12 | Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. ( Papp, LA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papp, LA | 1 |
1 trial available for piracetam and Panic Disorder
| Article | Year |
|---|---|
Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
Topics: Adolescent; Adult; Agoraphobia; Ambulatory Care; Anticonvulsants; Comorbidity; Diagnostic and Statis | 2006 |